sobuzoxane has been researched along with Lymphoma, B-Cell in 1 studies
sobuzoxane: used in treatment of leukemia L1210
Lymphoma, B-Cell: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okamoto, T | 1 |
| Nishimura, Y | 1 |
| Yamada, S | 2 |
| Itoh, T | 1 |
| Mori, A | 1 |
| Saheki, K | 1 |
| Okada, M | 1 |
| Takatsuka, H | 1 |
| Wada, H | 1 |
| Tamura, A | 1 |
| Fujimori, Y | 1 |
| Kakishita, E | 1 |
1 other study available for sobuzoxane and Lymphoma, B-Cell
| Article | Year |
|---|---|
Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP-16, for refractory or relapsed non-Hodgkin's lymphoma.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sch | 2000 |